UEDA, Y.; ISHII, H.; KITANO, T.; SHINDO, M.; MIYAZAWA, H.; ITO, K.; HIRAI, K.; KAKU, Y.; MORI, H.; HOSHINO, T.; OOKAWARA, S.; KAKEI, M.; TABEI, K.; MORISHITA, Y. Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers. Drug Target Insights, [S. l.], v. 10, n. 1, 2016. DOI: 10.33393/dti.2016.1422. Disponível em: https://journals.aboutscience.eu/index.php/dti/article/view/1422. Acesso em: 3 jul. 2024.